February 2022
-
Feb 28 2022
MOVe-Out RCT | Molnupiravir for COVID-19 in Outpatients
Spoon Feed Molnupiravir is an oral antiviral drug that has been shown to decrease risk of hospitalization or death at 29 days in patients with mild to moderate COVID-19 who are at risk for progression to severe diseaseRead More -
Feb 25 2022
Droperidol’s Reintroduction | A Risk-Benefit Analysis
Spoon Feed New research on droperidol shows that it is a safe and effective medication for a multitude of common ED presentations, despite an FDA black box warning for QTc prolongation in 2001.Read More -
Feb 24 2022
J-Tip and First-Attempt IV Success in Children
Spoon Feed J-Tip lidocaine infusion did not reduce first-attempt IV success and reduced pain compared to no local anesthetic in children.Read More -
Feb 23 2022
Outpatient Remdesivir for COVID-19
Spoon Feed Outpatient IV remdesivir was effective in reducing COVID-related hospitalization in high risk outpatients.Read More -
Feb 22 2022
Hyperkalemia + CKD – 5 or 10 Units of Insulin?
Spoon Feed In patients with moderate renal dysfunction (eGFR 15-59 mL/min/m2), giving 10 units vs 5 units of IV insulin for hyperkalemia did not result in a statistically significant difference in rates of hypoglycemia. Administering 10 units was shown to lower serum K by ~0.3 mmol/L more than 5 units.Read More -
Feb 21 2022
Apixaban or Rivaroxaban – Which Is Best for VTE?
Spoon Feed Apixaban and rivaroxaban are two of the most prescribed direct oral anticoagulants (DOACs), but there are limited head-to-head comparisons of the medications. This study finds apixaban is associated with lower rates of VTE recurrence, GI bleeds and ICH compared to rivaroxaban.Read More -
Feb 18 2022
Winning EEM 2022 Post! | TXA for Epistaxis – Clinical Controversy
Spoon Feed Given the negligible downsides of TXA and the known harms of packing, it’s worth a try in our patients with epistaxis.Read More -
Feb 17 2022
Noses Say Yay for TXA!
Spoon Feed TXA is a safe and effective topical treatment for epistaxis, with 3.5 times greater odds of bleeding cessation at first reassessment compared to placebo, lidocaine plus vasoconstrictors, or local anesthetics.Read More -
Feb 16 2022
SCOUT-CAP – Is Shorter Duration Better for Pediatric Pneumonia?
Spoon Feed A composite outcome encompassing both clinical response and adverse effects of antibiotics was superior in children who received 5 vs 10 days of antibiotics for pediatric community acquired pneumonia.Read More -
Feb 15 2022
Does IV Magnesium Make Kids with Asthma Worse?
Spoon Feed IV magnesium (IV-Mg) was associated with worsening asthma score in children, greater odds of hospitalization, and no acceleration of exacerbation resolution in hospitalized patients.Read More